Theravance Biopharma, Inc. (TBPH) Stock Consistently Declining, Here’s Why
Theravance Biopharma, Inc. (TBPH), a diversified biopharmaceutical company, has declined 5.24% in aftermarket trading session. Consequently, TBPH stock is trading at $7.59 at the time of